Chemoembolisation With Irinotecan Loaded DC Bead in Combination With Cetuximab and 5FU/LV in the First Line Treatment of Patients With KRAS Wildtype Metastatic Colorectal Cancer

Trial Profile

Chemoembolisation With Irinotecan Loaded DC Bead in Combination With Cetuximab and 5FU/LV in the First Line Treatment of Patients With KRAS Wildtype Metastatic Colorectal Cancer

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 03 Dec 2014

At a glance

  • Drugs Cetuximab (Primary) ; Fluorouracil (Primary) ; Irinotecan (Primary)
  • Indications Adenocarcinoma; Colorectal cancer; Liver metastases
  • Focus Adverse reactions
  • Most Recent Events

    • 03 Dec 2014 Status changed from not yet recruiting to withdrawn prior to enrolment, as reported by ClinicalTrials.gov record.
    • 05 Jul 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top